Matches in Nanopublications for { <http://www.nextprot.org/nanopubs#NX_P10276-3_MUTAGEN_74_74.RAsXJ_BP-FKJC3J8AquH707FDS7wKj2qQ7jR6kXBtl15s._1> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NX_P10276-3_MUTAGEN_74_74.RAsXJ_BP-FKJC3J8AquH707FDS7wKj2qQ7jR6kXBtl15s._1 type RangedSequencePosition NX_P10276-3_MUTAGEN_74_74.RAsXJ_BP-FKJC3J8AquH707FDS7wKj2qQ7jR6kXBtl15s.assertion.
- NX_P10276-3_MUTAGEN_74_74.RAsXJ_BP-FKJC3J8AquH707FDS7wKj2qQ7jR6kXBtl15s._1 type SO_0001148 NX_P10276-3_MUTAGEN_74_74.RAsXJ_BP-FKJC3J8AquH707FDS7wKj2qQ7jR6kXBtl15s.assertion.
- NX_P10276-3_MUTAGEN_74_74.RAsXJ_BP-FKJC3J8AquH707FDS7wKj2qQ7jR6kXBtl15s._1 comment "Cytoplasmic in the absence of ATRA and reduced transcriptional activity in the presence of ATRA. Low sumoylation levels in the presence of ATRA; when associated with R-399. Nuclear localization and enhanced transcriptional activity; when associated with R-166 and R-399. Primarily nuclear localization and enhanced ATRA-mediated transcriptional activity; when associated with R-147; R-166 and R-399." NX_P10276-3_MUTAGEN_74_74.RAsXJ_BP-FKJC3J8AquH707FDS7wKj2qQ7jR6kXBtl15s.assertion.
- NX_P10276-3_MUTAGEN_74_74.RAsXJ_BP-FKJC3J8AquH707FDS7wKj2qQ7jR6kXBtl15s._1 SIO_000053 NX_P10276-3_MUTAGEN_74_74.RAsXJ_BP-FKJC3J8AquH707FDS7wKj2qQ7jR6kXBtl15s._2 NX_P10276-3_MUTAGEN_74_74.RAsXJ_BP-FKJC3J8AquH707FDS7wKj2qQ7jR6kXBtl15s.assertion.
- NX_P10276-3_MUTAGEN_74_74.RAsXJ_BP-FKJC3J8AquH707FDS7wKj2qQ7jR6kXBtl15s._1 SIO_000053 NX_P10276-3_MUTAGEN_74_74.RAsXJ_BP-FKJC3J8AquH707FDS7wKj2qQ7jR6kXBtl15s._3 NX_P10276-3_MUTAGEN_74_74.RAsXJ_BP-FKJC3J8AquH707FDS7wKj2qQ7jR6kXBtl15s.assertion.